SERPINI2
gene geneOn this page
Also known as TSA2004MEPI
Summary
SERPINI2 (serpin family I member 2, HGNC:8945) is a protein-coding gene on chromosome 3q26.1, encoding Serpin I2 (O75830).
The gene encodes a member of a family of proteins that acts as inhibitors of serine proteases. These proteins function in the regulation of a variety of physiological processes, including coagulation, fibrinolysis, development, malignancy, and inflammation. Expression of the encoded protein may be downregulated during pancreatic carcinogenesis. Alternative splicing results in multiple transcript variants for this gene.
Source: NCBI Gene 5276 — RefSeq curated summary.
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_006217
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8945 |
| Approved symbol | SERPINI2 |
| Name | serpin family I member 2 |
| Location | 3q26.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TSA2004, MEPI |
| Ensembl gene | ENSG00000114204 |
| Ensembl biotype | protein_coding |
| OMIM | 605587 |
| Entrez | 5276 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 6 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000264677, ENST00000461846, ENST00000465031, ENST00000466903, ENST00000467583, ENST00000471111, ENST00000476257, ENST00000495108
RefSeq mRNA: 3 — MANE Select: NM_006217
NM_001012303, NM_001394327, NM_006217
CCDS: CCDS3200
Canonical transcript exons
ENST00000264677 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000780136 | 167446392 | 167446481 |
| ENSE00000780137 | 167449316 | 167449402 |
| ENSE00000780138 | 167452936 | 167453033 |
| ENSE00000780139 | 167465206 | 167465398 |
| ENSE00000780140 | 167465479 | 167465673 |
| ENSE00000780141 | 167467055 | 167467285 |
| ENSE00000826118 | 167441933 | 167442185 |
| ENSE00001831569 | 167474003 | 167474042 |
| ENSE00003635048 | 167471588 | 167471844 |
Expression profiles
Bgee: expression breadth ubiquitous, 175 present calls, max score 99.54.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4531 / max 512.6483, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 45448 | 0.4531 | 3 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.54 | gold quality |
| pancreas | UBERON:0001264 | 93.59 | gold quality |
| right uterine tube | UBERON:0001302 | 91.64 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.81 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.94 | gold quality |
| islet of Langerhans | UBERON:0000006 | 85.32 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 85.26 | gold quality |
| bronchus | UBERON:0002185 | 83.70 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 80.62 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 77.27 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 75.13 | silver quality |
| monocyte | CL:0000576 | 72.79 | gold quality |
| mononuclear cell | CL:0000842 | 72.35 | gold quality |
| caudate nucleus | UBERON:0001873 | 71.15 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 71.11 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.75 | gold quality |
| leukocyte | CL:0000738 | 70.51 | gold quality |
| nucleus accumbens | UBERON:0001882 | 69.87 | gold quality |
| oviduct epithelium | UBERON:0004804 | 69.85 | gold quality |
| fallopian tube | UBERON:0003889 | 69.80 | gold quality |
| ventricular zone | UBERON:0003053 | 66.33 | gold quality |
| corpus callosum | UBERON:0002336 | 66.19 | gold quality |
| right lung | UBERON:0002167 | 66.02 | gold quality |
| right atrium auricular region | UBERON:0006631 | 65.72 | gold quality |
| hypothalamus | UBERON:0001898 | 65.23 | gold quality |
| amygdala | UBERON:0001876 | 65.15 | gold quality |
| diaphragm | UBERON:0001103 | 65.03 | gold quality |
| cardiac atrium | UBERON:0002081 | 64.36 | gold quality |
| granulocyte | CL:0000094 | 63.54 | gold quality |
| olfactory bulb | UBERON:0002264 | 62.70 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-81547 | yes | 29.00 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
21 targeting SERPINI2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-12119 | 99.87 | 68.35 | 1653 |
| HSA-MIR-5002-5P | 99.76 | 70.84 | 1763 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-5580-3P | 99.70 | 69.41 | 2052 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
| HSA-MIR-6715B-5P | 99.64 | 69.63 | 1420 |
| HSA-MIR-7156-5P | 99.64 | 68.81 | 1369 |
| HSA-MIR-4261 | 99.59 | 70.30 | 3415 |
| HSA-MIR-4649-3P | 99.56 | 66.90 | 1783 |
| HSA-MIR-4269 | 99.55 | 69.89 | 1373 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-147B-5P | 99.45 | 70.62 | 2432 |
| HSA-MIR-329-5P | 99.27 | 68.11 | 1597 |
| HSA-MIR-6739-3P | 99.22 | 68.84 | 1843 |
| HSA-MIR-5701 | 98.97 | 69.54 | 1502 |
| HSA-MIR-3976 | 96.67 | 67.79 | 1187 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
| HSA-MIR-4524B-3P | 95.52 | 64.12 | 964 |
| HSA-MIR-574-3P | 92.35 | 64.27 | 41 |
Literature-anchored findings (GeneRIF, showing 1)
- The findings indicate that SERPINI2 is a promising candidate for further investigations of the genetic susceptibility to myopia. (PMID:22110064)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Serpini2 | ENSMUSG00000034139 |
| rattus_norvegicus | Serpini2 | ENSRNOG00000009903 |
Paralogs (36): SERPINB1 (ENSG00000021355), SERPINB3 (ENSG00000057149), SERPIND1 (ENSG00000099937), SERPINA4 (ENSG00000100665), SERPINE1 (ENSG00000106366), SERPINC1 (ENSG00000117601), SERPINA7 (ENSG00000123561), SERPINB6 (ENSG00000124570), SERPINF1 (ENSG00000132386), AGT (ENSG00000135744), SERPINE2 (ENSG00000135919), SERPINA10 (ENSG00000140093), SERPING1 (ENSG00000149131), SERPINH1 (ENSG00000149257), SERPINI1 (ENSG00000163536), SERPINA12 (ENSG00000165953), SERPINB7 (ENSG00000166396), SERPINB8 (ENSG00000166401), SERPINB12 (ENSG00000166634), SERPINF2 (ENSG00000167711), SERPINA9 (ENSG00000170054), SERPINA6 (ENSG00000170099), SERPINB9 (ENSG00000170542), SERPINA11 (ENSG00000186910), SERPINA5 (ENSG00000188488), SERPINA3 (ENSG00000196136), SERPINA1 (ENSG00000197249), SERPINB2 (ENSG00000197632), SERPINB13 (ENSG00000197641), SERPINB11 (ENSG00000206072), SERPINB4 (ENSG00000206073), SERPINB5 (ENSG00000206075), HMSD (ENSG00000221887), SERPINB10 (ENSG00000242550), SERPINE3 (ENSG00000253309), SERPINA2 (ENSG00000258597)
Protein
Protein identifiers
Serpin I2 — O75830 (reviewed: O75830)
Alternative names: Myoepithelium-derived serine protease inhibitor, Pancpin, Pancreas-specific protein TSA2004, Peptidase inhibitor 14
All UniProt accessions (4): A0A8V8PL11, C9J7N5, C9JWE1, O75830
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Tissue specificity. Expressed in pancreas and adipose tissues.
Similarity. Belongs to the serpin family.
RefSeq proteins (3): NP_001012303, NP_001381256, NP_006208* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000215 | Serpin_fam | Family |
| IPR023795 | Serpin_CS | Conserved_site |
| IPR023796 | Serpin_dom | Domain |
| IPR036186 | Serpin_sf | Homologous_superfamily |
| IPR042178 | Serpin_sf_1 | Homologous_superfamily |
| IPR042185 | Serpin_sf_2 | Homologous_superfamily |
Pfam: PF00079
UniProt features (8 total): glycosylation site 3, sequence variant 2, signal peptide 1, chain 1, site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O75830-F1 | 86.30 | 0.70 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 357–358 (reactive bond)
Glycosylation sites (3): 202, 207, 306
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 72 (showing top):
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53, chr3q26, BLALOCK_ALZHEIMERS_DISEASE_UP, MODULE_99, SCHLOSSER_SERUM_RESPONSE_DN, RYTTCCTG_ETS2_B, FOXJ2_02, TGGAAA_NFAT_Q4_01, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP
GO Biological Process (0):
GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular exosome (GO:0070062), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| binding | 1 |
| enzyme inhibitor activity | 1 |
| peptidase activity | 1 |
| peptidase regulator activity | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
370 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SERPINI2 | PI15 | O43692 | 694 |
| SERPINI2 | PI16 | Q6UXB8 | 670 |
| SERPINI2 | CPB1 | P15086 | 654 |
| SERPINI2 | PLAT | P00750 | 585 |
| SERPINI2 | RPE65 | Q16518 | 583 |
| SERPINI2 | PLAU | P00749 | 521 |
| SERPINI2 | WDR49 | Q8IV35 | 514 |
| SERPINI2 | PLG | P00747 | 507 |
| SERPINI2 | PLA2G1B | P04054 | 506 |
| SERPINI2 | ZBBX | A8MT70 | 450 |
| SERPINI2 | CEP290 | O15078 | 432 |
| SERPINI2 | ARFGEF3 | Q5TH69 | 389 |
| SERPINI2 | FAM124A | Q86V42 | 389 |
| SERPINI2 | ZNF80 | P51504 | 374 |
| SERPINI2 | ADAM18 | Q9Y3Q7 | 348 |
| SERPINI2 | PNLIPRP1 | P54315 | 348 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| UBQLN1 | SERPINI2 | psi-mi:“MI:0915”(physical association) | 0.900 |
| SERPINI2 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.900 |
| SERPINI2 | SGTB | psi-mi:“MI:0915”(physical association) | 0.670 |
| UBQLN1 | SERPINI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERPINI2 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SGTA | SERPINI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERPINI2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERPINI2 | HPCAL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERPINI2 | NUP58 | psi-mi:“MI:0915”(physical association) | 0.400 |
| SERPINI2 | H2BC9 | psi-mi:“MI:0915”(physical association) | 0.400 |
| BAG6 | SERPINI2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| PRKCE | PRPSAP2 | psi-mi:“MI:0914”(association) | 0.350 |
| SERPINI2 | LEPR | psi-mi:“MI:0914”(association) | 0.350 |
| SERPINI2 | UBQLN1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERPINI2 | SGTB | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERPINI2 | SGTA | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERPINI2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SERPINI2 | HPCAL1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (20): UBQLN1 (Two-hybrid), UBQLN1 (Two-hybrid), SERPINI2 (Biochemical Activity), SERPINI2 (Two-hybrid), SGTB (Two-hybrid), BAG6 (Two-hybrid), SERPINI2 (Two-hybrid), HPCAL1 (Two-hybrid), UBQLN1 (Two-hybrid), UBQLN2 (Two-hybrid), SGTB (Two-hybrid), SERPINI2 (Affinity Capture-MS), HIST1H2BH (Proximity Label-MS), NUPL1 (Proximity Label-MS), SNIP1 (Affinity Capture-MS)
ESM2 similar proteins: A2I7N3, B0UYL8, O75830, P01015, P01017, P01019, P05121, P05154, P05155, P05544, P05545, P05546, P07759, P09006, P11859, P13909, P20757, P20961, P22777, P29622, P31211, P32759, P47776, P49182, P50448, P50449, P70458, P79335, P97290, Q03734, Q5I2A0, Q5RCR2, Q5RDA8, Q60396, Q62975, Q63556, Q64268, Q6P4P1, Q6P734, Q7TMF5
Diamond homologs: A0A090BX51, A0A0K8RCY5, A0A0K8RJ89, A0A0K8RJV9, A5PJK0, A9RA96, B0CMB0, B1MTB7, B1MTC3, B2KI30, B3RFC3, B4USX2, E2RVI8, O02739, O08800, O35684, O54757, O54758, O54759, O54760, O73790, O73860, O75635, O75830, P01008, P01011, P01012, P01014, P05120, P05619, P12388, P17475, P19104, P22323, P22325, P22922, P23035, P29508, P29524, P30740
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2070 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:167442186:C:CC | acceptor_gain | 1.0000 |
| 3:167465227:T:TA | donor_gain | 1.0000 |
| 3:167467054:CCAT:C | donor_gain | 1.0000 |
| 3:167467084:A:AC | donor_gain | 1.0000 |
| 3:167467084:AT:A | donor_gain | 1.0000 |
| 3:167467084:ATCAT:A | donor_gain | 1.0000 |
| 3:167467085:T:C | donor_gain | 1.0000 |
| 3:167467147:T:TA | donor_gain | 1.0000 |
| 3:167442181:TGATT:T | acceptor_gain | 0.9900 |
| 3:167442183:ATTC:A | acceptor_loss | 0.9900 |
| 3:167442184:TT:T | acceptor_gain | 0.9900 |
| 3:167442184:TTCTA:T | acceptor_loss | 0.9900 |
| 3:167442185:TC:T | acceptor_loss | 0.9900 |
| 3:167442186:C:A | acceptor_loss | 0.9900 |
| 3:167442187:T:A | acceptor_loss | 0.9900 |
| 3:167449237:A:AC | donor_gain | 0.9900 |
| 3:167449238:C:CC | donor_gain | 0.9900 |
| 3:167449240:T:TA | donor_gain | 0.9900 |
| 3:167450648:A:C | donor_gain | 0.9900 |
| 3:167465228:C:A | donor_gain | 0.9900 |
| 3:167467067:TTTC:T | donor_gain | 0.9900 |
| 3:167467068:TTCT:T | donor_gain | 0.9900 |
| 3:167467070:C:CT | donor_gain | 0.9900 |
| 3:167467071:T:TT | donor_gain | 0.9900 |
| 3:167467241:C:CC | acceptor_gain | 0.9900 |
| 3:167473845:CATT:C | acceptor_gain | 0.9900 |
| 3:167442182:GATT:G | acceptor_gain | 0.9800 |
| 3:167442183:ATT:A | acceptor_gain | 0.9800 |
| 3:167449124:T:TA | donor_gain | 0.9800 |
| 3:167465201:CCAA:C | donor_loss | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000039759 (3:167461265 C>T), RS1000087923 (3:167460817 A>T), RS1000148186 (3:167454714 C>G), RS1000212167 (3:167467680 T>C), RS1000303592 (3:167450600 A>G), RS1000443903 (3:167475678 T>C), RS1000675637 (3:167452027 T>C), RS1000871670 (3:167456409 A>G), RS1000912836 (3:167444141 G>A), RS1000983032 (3:167476898 T>A), RS1000996932 (3:167462541 G>T), RS1001015416 (3:167444856 A>C), RS1001248205 (3:167477103 T>C), RS1001261842 (3:167478139 G>A), RS1001424351 (3:167455733 C>G)
Disease associations
OMIM: gene MIM:605587 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
8 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004048_1 | Fast beta electroencephalogram | 5.000000e-09 |
| GCST009391_575 | Metabolite levels | 7.000000e-06 |
| GCST009391_633 | Metabolite levels | 3.000000e-06 |
| GCST010135_19 | Oily fish consumption | 3.000000e-10 |
| GCST010136_12 | Fruit consumption | 1.000000e-08 |
| GCST010140_11 | Pork consumption | 3.000000e-10 |
| GCST010142_12 | Fish- and plant-related diet | 1.000000e-11 |
| GCST012489_93 | Heel bone mineral density x serum urate levels interaction | 8.000000e-09 |
EFO canonical traits (6, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004357 | electroencephalogram measurement |
| EFO:0021604 | hypoxanthine measurement |
| EFO:0010503 | inosine measurement |
| EFO:0008111 | diet measurement |
| EFO:0004531 | urate measurement |
| EFO:0009270 | heel bone mineral density |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | decreases methylation | 1 |
| sodium arsenite | affects methylation | 1 |
| vanadyl sulfate | increases expression | 1 |
| 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | increases expression, affects cotreatment, affects response to substance | 1 |
| bisphenol S | decreases methylation | 1 |
| Lipopolysaccharides | affects response to substance, increases expression, affects cotreatment | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.